| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 07/03/2008 | WO2008079206A1 Nucleoside cyclic phosphoramidates for the treatment of rna-dependent rna viral infection |
| 07/03/2008 | US20080161550 Process for the preparation of 4'-Azido cytidine derivatives |
| 07/03/2008 | CA2672613A1 Nucleoside cyclic phosphoramidates for the treatment of rna-dependent rna viral infection |
| 07/02/2008 | EP1939210A1 Method for purification of cytidinediphosphoric choline |
| 07/02/2008 | EP1937825A2 Modified 4'-nucleosides as antiviral agents |
| 07/02/2008 | EP1937702A2 Labeled nucleotide analogs and uses therefor |
| 07/02/2008 | EP1899361A4 Reagent for the improved synthesis of isoguanosine-containing oligonucleotides |
| 07/02/2008 | EP1537488A4 Systems and methods for predicting oligonucleotide melting temperatures (tms) |
| 07/02/2008 | EP1401851B1 Two-stage protective groups for the synthesis of biopolymers |
| 07/01/2008 | US7393954 Process for the production of pentostatin aglycone and pentostatin |
| 07/01/2008 | US7393839 Crystalline forms A and B of Levovirin valinate hydrochloride (2-(S)-amino-3-methyl-butyric acid 5S-(3-carbamoyl-[1,2,4]triazol-1-yl)-3R,4S-dihydroxy-tetrahydrofuran-2S-yl methyl ester, monohydrochloride): hemihydrate; Hepatitis C virus; physical and chemical stability; solubility and flowability |
| 06/26/2008 | WO2008001109A3 Method of covalently linking a carbohydrate or polyalkylene oxide to a peptide, precursors for use in the method and resultant products |
| 06/26/2008 | US20080154064 Method of fluorination |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153774 4' -C-substituted-2-haloadenosine derivative |
| 06/26/2008 | US20080153773 Inhibits modulation of Protein phosphatase 2A (PP2A) by PTPA; and ATPase inhibitors; used to treat disorders in which PTPA ATPase activity |
| 06/26/2008 | US20080153095 Triphosphates having gamma-phosphate with a detectable group attached; detection using charge coupled device camera or photodiode |
| 06/26/2008 | US20080152702 Improved blood circulation lifetime of drug-carrying liposomes having a surface coating of releasable hydrophilic polymer covalently and reversibly linked to an phospholipid or polypeptide through a dithiobenzyl linkage |
| 06/26/2008 | US20080152621 Antiviral nucleosides |
| 06/25/2008 | EP1670928A4 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 06/25/2008 | CN101206201A Clofarabine as well as method for separating and measuring enantiomer thereof |
| 06/25/2008 | CN100396785C Resoldution method for racemic compound of nucleoside enantiomorph |
| 06/25/2008 | CN100396692C Diuridine tetraphosphate or salt crystal thereof, process for producing the same, and process for producing the compounds |
| 06/24/2008 | US7390890 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 06/24/2008 | US7390791 Prodrugs of phosphonate nucleotide analogues |
| 06/19/2008 | WO2008072963A1 Flavour modulating derivative of a carboxylic acid and a purine, pyrimidine, nucleoside or nucleotide |
| 06/19/2008 | WO2008071571A1 Process for preparation of 4'-azido cytidine derivatives |
| 06/19/2008 | US20080146787 nucleoside monomers protected with thioether substituted aryl carbonate protecting groups; oligonucleotides, using such protected nucleoside monomer monomers, as well as nucleic acids |
| 06/19/2008 | US20080146517 Indole Antiviral Compositions And Methods |
| 06/19/2008 | US20080145451 Composition for relieving discomfort |
| 06/19/2008 | US20080145372 Bioreductively-Activated Prodrugs |
| 06/18/2008 | EP1931693A2 Process for preparing gemcitabine and associated intermediates |
| 06/18/2008 | EP1931692A2 Selective o-acylation of nucleosides |
| 06/18/2008 | EP1931691A1 Odcase inhibitors for the treatment of malaria |
| 06/18/2008 | EP1931343A2 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 06/18/2008 | CN101203525A Process of making an alpha-anomer enriched 2-deoxy-2,2-diflouro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside |
| 06/18/2008 | CN101203524A Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-d-ribofuranosyl nucleosides |
| 06/18/2008 | CN101200481A Technique for extracting cordycepin from artificial Chinese caterpillar fungus culture medium residue |
| 06/18/2008 | CN101200467A New compound generated by streptomycete and preparation method thereof |
| 06/18/2008 | CN100395256C Crystallization process of 5'-nucleoside-sodium phosphate |
| 06/17/2008 | US7388094 using 1-beta-D-arabinofuranosyluracil in 3',5'-hydroxyl-protected form as substrate, target trifluoromethanesulfonylation at 2'-position and subsequent nucleophilic SN2 substitution reaction by fluorine anion (F-) at 2'-position proceed well under specific conditions |
| 06/17/2008 | US7388092 Linkers for donor dyes to acceptor dyes for energy transfer between dyes with fluorescence |
| 06/17/2008 | US7387614 Drug delivery to the inner ear and methods of using same |
| 06/17/2008 | CA2331737C Agents for relieving side effects caused by use of an anti-tumour agent |
| 06/17/2008 | CA2309202C Adenosine a1 receptor agonists |
| 06/17/2008 | CA2202487C Fused pyrrolocarbazoles |
| 06/15/2008 | CA2610862A1 Method for the production of cladribine |
| 06/12/2008 | WO2008067825A1 Hoogsteen-type triplex formation of pyrene labelled probes for nucleic acid detection in fluorescence assay |
| 06/12/2008 | US20080139802 Converting 2'-deoxy-2'-fluoro-2'-methyl-D-ribonolactones derivatives to 3-fluoro-3-methyl-2-chlorofuran compounds using chlorinating agent such as sulfuryl chloride, thionyl chloride or phosphorus oxychloride and tetrabutylammonium bromide |
| 06/12/2008 | CA2670937A1 Photocleavable labeled nucleotides and nucleosides and labeled nucleotides and nucleosides and methods for their use in dna sequencing |
| 06/11/2008 | EP1928475A2 Antiviral phosphoramidates of 4'-substituted pronucleotides |
| 06/11/2008 | EP1492803B1 New analogs of nitrobenzylthioinosine |
| 06/11/2008 | EP1278760B1 Methods for multiplexed determination of target species using tag library compounds, compositions and kits |
| 06/11/2008 | CN100393722C Inhibitors of nucleoside metabolism |
| 06/10/2008 | US7385050 Cleavable linker for polynucleotide synthesis |
| 06/10/2008 | CA2322790C Granulatimide derivatives for use in cancer treatment |
| 06/05/2008 | US20080131895 Massive parallel method for decoding DNA and RNA |
| 06/05/2008 | CA2663618A1 Azole nucleosides and use as inhibitors of rna and dna viral polymerases |
| 06/04/2008 | EP1926829A2 Labelled modified guanine-containing nucleosides and nucleotides comprising a fluorophore attached to the base through a linking group comprising a polyethylene glycol spacing group and methods for their use |
| 06/04/2008 | CN101190934A Method for preparing Zidovudine azide intermediate by phase transition method |
| 06/04/2008 | CN100391966C Synthesis method of 2-deoxy-2',2'-difluoro cytidine |
| 06/04/2008 | CN100391965C Process for preparing midolthromycin derivatives |
| 06/03/2008 | US7381807 Of given nucleotide sequence; encapsulated in slow release delivery vehicle; includes viral or bacterial antigen; increases cell proliferation, differentiation, cytokine and antibody production for lymphocytes |
| 06/03/2008 | US7381714 A1 adenosine receptor agonists |
| 06/03/2008 | CA2305760C Inhibitors of nucleoside metabolism |
| 06/03/2008 | CA2279846C Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 05/29/2008 | WO2008062206A2 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus |
| 05/29/2008 | US20080125381 Such as 7-(2-thienyl)-3-(2-deoxy- beta -D-ribofuranosyl)-3H-imidazo[4,5-b]pyridine; anticancer agents |
| 05/29/2008 | US20080124708 Labeled nucleotide composition |
| 05/29/2008 | US20080124328 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 05/29/2008 | CA2670328A1 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus |
| 05/28/2008 | EP1925624A1 Use of squalenic acid for the formulation of an active principle in nanoparticle state |
| 05/28/2008 | EP1814895A4 Apparatus and system having dry control gene silencing compositions |
| 05/28/2008 | EP1585529A4 Process for the production of 2'-branched nucleosides |
| 05/28/2008 | EP1540007A4 Nucleic acid labeling methods |
| 05/28/2008 | EP1456218B1 Avermectin b1 derivatives having an aminosulfonyloxy substituent in the 4''-position |
| 05/28/2008 | EP1178051B1 Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside |
| 05/28/2008 | CN101189249A Phosphono-pent-2-en-1-yl nucleosides and analogs |
| 05/28/2008 | CN101186937A Non-homogeneous systems for the resolution of enantiomeric mixtures |
| 05/28/2008 | CN100390153C Intermediate for producing novel pyrazine derivatives |
| 05/27/2008 | US7378517 Donor dye with absorption maxima at 250-450 nm wavelength; acceptor dye emitting light with maxima greater than 500 nm. in response to absorbing energy emitted by doner; especially with donor and acceptor dyes linked together; labeled with nucleoside, mono, di or triphosphate of nucleosides, nucleotides |
| 05/27/2008 | US7378402 4-Amino-1-((2R,3S,4S,5R)-5-azido-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one; hepatitis C virus. |
| 05/27/2008 | US7378401 Administering (5-fluorouridine)-5'-phosphoric acid (3-dodecylmercapto-2-decyloxy)propylester or a salt; actinic keratosis |
| 05/27/2008 | US7378400 Method to reduce an inflammatory response from arthritis |
| 05/22/2008 | WO2008059130A1 Thionucleosides and pharmaceutical applications |
| 05/22/2008 | WO2008039997A3 Nucleobase conjugates with cationic backbone linkers |
| 05/22/2008 | WO2006138676A8 Aptamers that bind to prion protein |
| 05/22/2008 | US20080119645 Amidites and Methods of Rna Synthesis |
| 05/22/2008 | US20080119422 antidiabetic agents; 4-chloro-3-(4-ethylphenylmethyl)-1-( beta -D-glucopyranosyl)indole; hypoglycemic agent, wound healing agent, antilipemic agents, hypotensive agent; chemical synthesis with a chemical intermediates |
| 05/22/2008 | CA2667569A1 Thionucleosides and pharmaceutical applications |
| 05/21/2008 | EP0781138B1 Lipid analogs for treating viral infections |
| 05/21/2008 | CN100389119C (trans)-2-deoxy-2-(fluoromethano)-4-R acyl-cytidine compound, preparation process and use thereof |
| 05/20/2008 | US7375235 Viricides; such as 2-bromo-5,6-dichlorobenzimidazole; cyclizing 4,5-dichloro-o-phenylenediamine with carbonyl di-imidazole |
| 05/20/2008 | US7375202 Human virus causing severe acute respiratory syndrome (SARS) and uses thereof |
| 05/20/2008 | US7374882 Method for base sequencing and biologically active nucleic acids |
| 05/15/2008 | WO2008055875A1 Compound having inhibitory activity on a rho-gtpase cell protein, a process for obtaining the same, pharmaceutical compositions comprision thereof and a method for the treatment of a rho-gtpase cell protein-mediated condition |
| 05/15/2008 | US20080113927 Indolopyrrolocarbazole derivatives and anti-tumor agent |
| 05/15/2008 | DE102006053690A1 New anionic cyclopentadienyl-carbohydrate compounds useful in the preparation of metallocene-carbohydrate compound, which is useful to treat cancer |
| 05/14/2008 | EP1919930A2 New nucleic acid base pairs |
| 05/14/2008 | EP1919929A2 Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs |